| PGR2021-00035 | Chengdu Kanghong Biotechnology Co., Ltd. et al. v. Regeneron Pharmaceuticals, Inc. | Jan 7, 2021 |
| 1:22-cv-00061 | Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. | Aug 2, 2022 |
| 1:23-cv-00089 | Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc. | Nov 8, 2023 |
| 1:23-cv-00094 | Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis, CO., LTD., | Nov 21, 2023 |
| 1:23-cv-00106 | Regeneron Pharmaceuticals, Inc. v. Samsung Bioepis Co., Ltd. | Dec 27, 2023 |
| 2:24-cv-00264 | Regeneron Pharmaceuticals, Inc. v. Amgen, Inc. | Jan 10, 2024 |
| 1:24-md-03103 | In Re: Aflibercept Patent Litigation | Apr 11, 2024 |
| 1:24-cv-00039 | Regeneron Pharmaceuticals, Inc. v. Amgen, Inc. | Apr 16, 2024 |
| 1:24-cv-00053 | Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc. | May 17, 2024 |
| 2:24-cv-08760 | REGENERON PHARMACEUTICALS, INC. v. SANDOZ INC. | Aug 26, 2024 |
| IPR2025-00176 | Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc. | Nov 20, 2024 |
| IPR2025-00233 | Formycon AG v. Regeneron Pharmaceuticals, Inc. | Dec 2, 2024 |
| IPR2025-00456 | Celltrion, Inc. v. Regeneron Pharmaceuticals, Inc. | Jan 15, 2025 |
| IPR2025-01268 | Fresenius Kabi SwissBioSim GmbH et al. v. Regeneron Pharmaceuticals, Inc. | Jul 14, 2025 |
| IPR2025-01269 | Fresenius Kabi SwissBiosim, GmbH et al. v. Regeneron Pharmaceuticals, Inc. | Jul 14, 2025 |
